The outlook for advancing healthcare globally in 2025 provides grounds for cautious optimism. The world is finally fully out from under the burden of the COVID-19 global pandemic, and multiple ongoing efforts by international stakeholders point to opportunities for real progress with programs that will benefit health systems and populations around the world, and the scientific evidence to support such efforts is robust. Yet, there are also potential threats from the emergence of new diseases, macro-economic and geo-political stress points, and many other longstanding issues that inhibit the advancement of health globally and remain unresolved.
In this research brief, we look at a select few of the many opportunities and challenges, consider the efforts underway to improve health and advance health outcomes, and identify seven key indicators we will be watching to monitor whether advances are being made globally during the course of 2025.
These are not predictions of what will happen, but rather some specific measurable markers of progress that we will be able to review at the end of this year.
The 2025 indicators of progress for advancing health globally are:
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
IQVIA is working to advance public health in partnership with other companies, governments, and non-governmental organizations, from fighting opioid addiction to addressing antibiotic resistance.
Accelerate the development of new therapies.
.svg){kind=icon}
